Model of Coronavirus

About Coronavirus Disease 2019 (COVID-19)

Coronavirus disease 2019 (COVID-19) is a respiratory illness that spreads from person to person, mainly between people who are in close contact with one another (within about 6 feet) through respiratory droplets. Droplets are produced when an infected person speaks, sings, coughs or sneezes.

The COVID-19 virus is not that same as the coronaviruses that commonly circulate among humans and cause mild illness, like the common cold.

Everyone 6 month and older is elligible for a COVID-19 vaccine

COVID-19 Symptoms

Mild symptoms of COVID-19 include fever, cough, headache, runny nose, loss of sense of smell/taste, sore throat, and/or diarrhea. If you have mild symptoms you should seek testing

Call 911 or go to the emergency room if you have severe symptoms, including difficulty breathing, chest pain, confusion, fever that doesn't respond to medication.


 Test for COVID-19

If you are experiencing COVID-19 symptoms, you should self-isolate and get tested.

If You Test Positive


When To Isolate

Help prevent the spread of disease by isolating at home for at least 5 days after testing positive for COVID-19. Your isolation timeline is based on severity of symptoms.

  • You may end isolation after 5 full days if you are fever-free for 24 hours without the use of fever-reducing medication, and your symptoms are improving. Wear a well-fitting mask around others for the following five days.
  • If you had moderate illness (if you experienced shortness of breath or had difficulty breathing), or severe illness (you were hospitalized) due to COVID-19, or you have a weakened immune systemisolate through day 10.
  • Regardless of when you end isolation, avoid being around people who are more likely to get very sick from COVID-19 until at least day 11.
  • Wear a high-quality mask when indoors around others at home and in public. Do not go places where you are unable to wear a mask until you are able to discontinue masking, including public transportation and travel settings.
  • Consider using rapid antigen tests*. With two sequential negative tests 48 hours apart, you may remove your mask sooner than day 10.

*Negative tests results from over-the-counter antigen tests do not rule out SARS-CoV-2 infection, and should not be used as the sole basis for treatment or patient management decisions, including infection control decisions.

Contact Tracing
  • If you test positive, a case worker may reach out to you. 
  • APH case investigators will never ask for Social Security, Medicaid, insurance, immigration, or financial information. 
  • If you believe you are receiving a scam call, request the name, title, and call back number and you can verify the information with the City of Austin by calling 311 to ask for that person. 
  • Contact tracing helps prevent further transmission of COVID-19 by identifying, monitoring and supporting individuals who have been exposed

When To Quarantine

Review this flowchart to determine how long to quarantine after being exposed to COVID-19.

Wear a mask as soon as you find out you were exposed.
Start counting from Day 1

  • Day 0 is the day of your last exposure to someone with COVID-19
  • Day 1 is the first full day after your last exposure

Get tested at least 5 days after you last had close contact with someone who has COVID-19.

If negative, continue wearing a well-fitted mask for 10 days any time you're around others inside your home or in public. You can still develop COVID-19 up to 10 days after you have been exposed.


Treatments: Monoclonal Infusions 

For Treatment

Omicron has numerous mutations in the spike protein that has reduced the efficacy of several of the monoclonal antibodies, especially bamlanivimab plus etesevimab and casirivimad plus imdevimab. Sotrovimab does have 85% hospitalization risk reduction against omicron. For referral to the Regional Infusion Center (RIC) for MAB treatment, click here.

For Preexposure Prophylaxis:

The MAC clinic is treating Central Texas patients eligible for Evusheld, a monoclonal antibody for preexposure prophylaxis used in adults and children 12y or older weighing at least 40kg, with moderate to severe immunocompromise or who receive immunosuppressive medications and may not mount an adequate response to a Covid-19 vaccination. Evusheld is not for treatment of Covid-19.

Providers are required to have a clinical conversation regarding risk and benefits with their patient before completing and submitting the referral form. For HIPAA compliant referral to the Prep MAC Clinic for Evusheld therapy, click here.

EVUSHELDTM – Clinical Considerations

  • Not authorized for treatment of COVID-19, nor for post-exposure prophylaxis of COVID19 in individuals who have been exposed to someone infected with SARS-CoV-2.
  • Pre-exposure prophylaxis with EVUSHELD is not a substitute for vaccination in individuals for whom COVID-19 vaccination is recommended.
  • In individuals who have received a COVID-19 vaccine, EVUSHELD should be administered at least two weeks after vaccination.
  • Examples of medical conditions or treatments that may result in moderate to severe immune compromise and an inadequate immune response to COVID-19 vaccination are provided in the Health Care Provider Fact Sheet.

Health Care Provider Fact Sheet